Trends in ED visits for ADEs in children aged <6 years, United States, 2004–2013. A, Estimated number of ED visits for unsupervised medication exposures. B, Estimated number of ED visits for ADEs after caregiver administration. C, Estimated proportion of ED visits for ADEs attributed to unsupervised exposures.
Estimates are based on the NEISS-CADES project, 2010 through 2013. Estimates based on <20 cases or with a total 4-year estimate <1200 are not shown (–). Twenty-nine ED visits involving a medication in which the dosage form was unspecified are not shown.
↵a Denotes cases in which the child accessed an oral medication, but there was not enough information to determine whether it was an oral liquid or an oral solid dosage form.
National Estimates of Medications Commonly Implicated in ED Visits for Unsupervised Exposures by Children Aged <6 Years, United States, 2010–2013
Estimates based on the NEISS-CADES project, 2010 through 2013. Medications implicated in at least 3% of estimated ED visits for the 3 most commonly implicated dosage form and prescription status combinations are listed.